Trupanion (NASDAQ:TRUP – Free Report) had its price objective cut by Piper Sandler from $57.00 to $52.00 in a research report sent to investors on Thursday,Benzinga reports. They currently have an overweight rating on the financial services provider’s stock.
Other equities research analysts have also issued research reports about the company. Northland Securities boosted their target price on Trupanion from $45.00 to $50.00 and gave the company a “market perform” rating in a research note on Thursday, October 31st. Stifel Nicolaus boosted their target price on Trupanion from $42.00 to $44.00 and gave the company a “hold” rating in a research note on Monday, January 6th. Two analysts have rated the stock with a hold rating, four have assigned a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat.com, Trupanion presently has an average rating of “Moderate Buy” and an average price target of $46.60.
Get Our Latest Research Report on Trupanion
Trupanion Price Performance
Trupanion (NASDAQ:TRUP – Get Free Report) last released its earnings results on Wednesday, February 19th. The financial services provider reported $0.04 earnings per share for the quarter, missing analysts’ consensus estimates of $0.06 by ($0.02). Trupanion had a negative net margin of 0.75% and a negative return on equity of 3.11%. The company had revenue of $337.31 million during the quarter, compared to the consensus estimate of $335.41 million. As a group, equities analysts expect that Trupanion will post 0.13 EPS for the current year.
Insider Buying and Selling at Trupanion
In other Trupanion news, CFO Fawwad Qureshi sold 9,867 shares of the company’s stock in a transaction that occurred on Friday, November 29th. The stock was sold at an average price of $53.08, for a total transaction of $523,740.36. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, SVP Emily Dreyer sold 900 shares of the company’s stock in a transaction that occurred on Monday, November 25th. The stock was sold at an average price of $54.55, for a total value of $49,095.00. Following the transaction, the senior vice president now owns 23,808 shares in the company, valued at $1,298,726.40. This trade represents a 3.64 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 11,581 shares of company stock valued at $615,159 in the last 90 days. Insiders own 5.50% of the company’s stock.
Institutional Inflows and Outflows
A number of hedge funds and other institutional investors have recently made changes to their positions in the company. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its holdings in shares of Trupanion by 14.2% during the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 89,184 shares of the financial services provider’s stock worth $4,299,000 after acquiring an additional 11,119 shares during the period. Squarepoint Ops LLC grew its stake in shares of Trupanion by 32.5% in the 4th quarter. Squarepoint Ops LLC now owns 211,900 shares of the financial services provider’s stock worth $10,214,000 after buying an additional 52,031 shares during the last quarter. State of Wyoming grew its stake in shares of Trupanion by 111.4% in the 4th quarter. State of Wyoming now owns 11,158 shares of the financial services provider’s stock worth $538,000 after buying an additional 5,880 shares during the last quarter. Sherbrooke Park Advisers LLC purchased a new stake in shares of Trupanion in the 4th quarter worth approximately $347,000. Finally, Raiffeisen Bank International AG purchased a new stake in shares of Trupanion in the 4th quarter worth approximately $2,505,000.
About Trupanion
Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.
Featured Stories
- Five stocks we like better than Trupanion
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- Ray Dalio’s Bridgewater Loaded Up on These Stocks in Q4 2024
- The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number
- Walmart Faces Tariff Headwinds, Consumer Trends Remain Positive
- How Can Retail Investors Trade the Toronto Stock Exchange (TSX)?
- Tesla: 2 Reasons to Buy, 1 Reason to Run
Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.